{"mainPropery":{"diseaseId":9572,"diseaseName":"Papillary renal cell carcinoma","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9572/papillary-renal-cell-carcinoma","synonyms":["RCCP","Renal adenocarcinoma","Papillary renal cell carcinoma, sporadic - (subtype)","Papillary renal cell carcinoma, bilateral - (subtype)","Papillary renal cell carcinoma, multiple - (subtype)","Papillary renal cell carcinoma, familial - (subtype)","Papillary renal carcinoma, malignant - (subtype)","Papillary renal cell adenocarcinoma"],"synonyms-with-source":[{"name":"RCCP"},{"name":"Renal adenocarcinoma"},{"name":"Papillary renal cell carcinoma, sporadic - (subtype)"},{"name":"Papillary renal cell carcinoma, bilateral - (subtype)"},{"name":"Papillary renal cell carcinoma, multiple - (subtype)"},{"name":"Papillary renal cell carcinoma, familial - (subtype)"},{"name":"Papillary renal carcinoma, malignant - (subtype)"},{"name":"Papillary renal cell adenocarcinoma","source":"Orphanet"}],"identifiers":[{"identifierType":"OMIM","identifierId":"605074"},{"identifierType":"ORPHANET","identifierId":"319298"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases"},{"diseaseTypeId":26,"diseaseTypeName":"Kidney and Urinary Diseases","source":"Orphanet"},{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[{"resourceID":2769,"resourceName":"Action to Cure Kidney Cancer","abbreviation":"ACKC","address1":"150 West 75th St. ","address2":"Suite 4","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10023","country":"United States","phone":"212-714-5341","tty":"","tollFree":"","fax":"","email":"http://www.ackc.org/contact-us/","url":"http://www.ackc.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/605074' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=605074' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Papillary renal cell carcinoma. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Papillary+renal+cell+carcinoma%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Papillary renal cell carcinoma. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='https://www.ncbi.nlm.nih.gov/gtr/conditions/C1306837/' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022205' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=319298' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1543,"resourceId":2171,"resourceName":"National Cancer Institute","descriptionText":"The <a href='http://www.cancer.gov/cancertopics/pdq/treatment/renalcell/Patient/page1' target='_blank'>National Cancer Institute</a> provides the most current information on cancer for patients, health professionals, and the general public.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1650,"resourceId":500,"resourceName":"Cancer.net","descriptionText":"<a href='http://www.cancer.net/cancer-types/hereditary-papillary-renal-cell-carcinoma' target='_blank'>Cancer.Net</a> provides oncologist-approved cancer information from the American Society of Clinical Oncology and has information about Papillary renal cell carcinoma.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:4465' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2160,"resourceId":3368,"resourceName":"Patient Access Network Foundation","descriptionText":"<a href='https://panfoundation.org/index.php/en/patients/assistance-programs/renal-cell-carcinoma' target='_blank'>Patient Access Network Foundation</a> (PAN Foundation) has Assistance Programs for those with health insurance who reside in the United States. The disease fund status can change over time, so you may need to check back if funds are not currently available.&nbsp;","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":2162,"resourceId":3371,"resourceName":"The Assistance Fund","descriptionText":"<a href='https://tafcares.org/patients/covered-diseases/' target='_blank'>The Assistance Fund</a> provides various services, including education and financial aid, to help patients with a chronic or serious illness cover the cost of FDA-approved medications. Patients must be U.S citizens or permanent residents.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":10115,"questionText":"What is papillary renal cell carcinoma (PRCC)?","answerText":"<strong>Papillary renal cell carcinoma</strong> (PRCC) is a type of cancer that occurs in the kidneys. It accounts for about 10-15% of all renal cell carcinomas.[10635]<a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000516.htm\" target=\"_blank\" tabindex=\"-1\">R</a><a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000516.htm\" target=\"_blank\" tabindex=\"-1\">enal cell carcinoma</a><a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000516.htm\" target=\"_blank\" tabindex=\"-1\">s</a> are a type of kidney cancer that develop in&nbsp;the lining of very small tubes (tubules) in the kidney.[10634]The term \"papillary\" describes the finger-like projections that can be found in most of the tumors.[10636] PRCC can be divided into two types: type 1, which is more common and usually grows more slowly and type 2, which are usually more aggressive .[10635]Though the exact cause of papillary renal cell carcinoma is unknown, smoking, obesity, and genetic predisposition conditions (such as <a href=\"https://rarediseases.info.nih.gov/gard/10096/hereditary-leiomyomatosis-and-renal-cell-cancer/resources/1\" target=\"_blank\">hereditary leiomyomatosis and renal cell cancer</a>) may contribute to the development of this type of cancer.  Treatment often begins with surgery to remove as much of the cancer as possible, and may be followed by <a href=\"http://www.cancer.gov/publications/dictionaries/cancer-terms?CdrID=44971\" target=\"_blank\">radiation therapy</a>, <a href=\"http://www.cancer.gov/publications/dictionaries/cancer-terms?CdrID=45214\" target=\"_blank\">chemotherapy</a>, <a href=\"http://www.cancer.gov/publications/dictionaries/cancer-terms?CdrID=45617\" target=\"_blank\">biological therapy</a>, or <a href=\"http://www.cancer.gov/publications/dictionaries/cancer-terms?CdrID=270742\" target=\"_blank\">targeted therapy</a>.[10636]","dateModified":"2016-02-11T14:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":13157,"relatedDiseaseName":"Hereditary papillary renal cell carcinoma","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":7386,"phenoTypeName":"Incomplete penetrance","percentRanges":"-"},{"phenoTypeId":12112,"phenoTypeName":"Papillary renal cell carcinoma","percentRanges":"-"},{"phenoTypeId":8123,"phenoTypeName":"Somatic mutation","percentRanges":"-"}],"medicalProducts":[{"productId":51,"genericName":"Sorafenib","tradeName":"Nexavar","tradeLink":"http://www.nexavar-us.com/","manufacturer":"","sponsor":"Bayer Pharmaceutical Corporation","indication":"Treatment of patients with advanced renal cell carcinoma.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/rn/475207-59-1","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a607051.html"},{"productId":101,"genericName":"Aldesleukin","tradeName":"Proleukin®","tradeLink":"https://www.proleukin.com/","manufacturer":"","sponsor":"Chiron Corporation","indication":"Treatment of adults (>18 years old) with metastatic renal cell carcinoma.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/Proleukin","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a692009.html"},{"productId":482,"genericName":"Temsirolimus","tradeName":"Torisel®","tradeLink":"http://torisel.com/","manufacturer":"","sponsor":"Wyeth Pharmaceuticals, Inc.","indication":"Treatment of advanced renal cell carcinoma","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Torisel","medlinePlusLink":"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a607071.html"}],"EncodedName":"Papillary_renal_cell_carcinoma"}